We are live on ! Find out more
JAM

Jupiter Asset Management Portfolio holdings

AUM $18.8B
1-Year Est. Return 29.2%
This Fund
S&P 500
This Quarter Est. Return
+7.9%
1 Year Est. Return
+29.2%
3 Year Est. Return
+89.56%
5 Year Est. Return
+106.39%
10 Year Est. Return
+461.4%
AUM
$9.11B
AUM Growth
+$286M
Cap. Flow
-$399M
Cap. Flow %
-4.38%
Top 10 Hldgs %
19.89%
Holding
673
New
125
Increased
192
Reduced
154
Closed
128

Top Buys

Rank Stock Value
1
INTC icon
Intel
INTC
+$108M
2
C icon
Citigroup
C
+$74.1M
3
MRK icon
Merck
MRK
+$72.5M
4
NRG icon
NRG Energy
NRG
+$63.9M
5
VICI icon
VICI Properties
VICI
+$60.6M

Sector Composition

Rank Sector Weight
1 Technology 21.91%
2 Financials 13.96%
3 Consumer Discretionary 11.91%
4 Healthcare 11.57%
5 Industrials 10.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALB icon
451
Albemarle
ALB
$14B
$410K ﹤0.01%
1,748
+161
+10% +$39.8K
BEP icon
452
Brookfield Renewable
BEP
$10.2B
$407K ﹤0.01%
11,412
+2,440
+27% +$89.9K
TRTX
453
TPG RE Finance Trust
TRTX
$619M
$407K ﹤0.01%
33,293
SANM icon
454
Sanmina
SANM
$10.4B
$404K ﹤0.01%
9,716
-3,279
-25% -$129K
SJI
455
DELISTED
South Jersey Industries, Inc.
SJI
$395K ﹤0.01%
+15,138
New +$360K
COP icon
456
ConocoPhillips
COP
$145B
$394K ﹤0.01%
5,447
-26,558
-83% -$1.94M
RIG icon
457
Transocean
RIG
$5.7B
$392K ﹤0.01%
+138,587
New +$470K
MOV icon
458
Movado Group
MOV
$866M
$388K ﹤0.01%
+9,220
New +$348K
NEE icon
459
NextEra Energy
NEE
$181B
$386K ﹤0.01%
+4,162
New +$360K
ORGO icon
460
Organogenesis Holdings
ORGO
$301M
$385K ﹤0.01%
+41,374
New +$439K
STLA icon
461
Stellantis
STLA
$21.3B
$378K ﹤0.01%
19,911
-1,675
-8% -$32.3K
SWBI icon
462
Smith & Wesson
SWBI
$660M
$377K ﹤0.01%
+21,287
New +$439K
CASA
463
DELISTED
Casa Systems, Inc. Common Stock
CASA
$377K ﹤0.01%
67,020
LTHM
464
DELISTED
Livent Corporation
LTHM
$375K ﹤0.01%
15,158
+879
+6% +$23.9K
WTRG icon
465
Essential Utilities
WTRG
$11B
$374K ﹤0.01%
6,992
+1,495
+27% +$72.6K
PXD
466
DELISTED
Pioneer Natural Resource Co.
PXD
$374K ﹤0.01%
2,063
-134
-6% -$24.7K
VIVO
467
DELISTED
Meridian Bioscience Inc
VIVO
$373K ﹤0.01%
18,558
CATY icon
468
Cathay General Bancorp
CATY
$4.27B
$372K ﹤0.01%
+8,631
New +$372K
CAT icon
469
Caterpillar
CAT
$382B
$358K ﹤0.01%
1,738
-144,947
-99% -$29.2M
HUBB icon
470
Hubbell
HUBB
$25.2B
$346K ﹤0.01%
1,670
+357
+27% +$71.4K
ECHO
471
EchoStar
ECHO
$24.8B
$346K ﹤0.01%
+13,140
New +$347K
VNDA icon
472
Vanda Pharmaceuticals
VNDA
$315M
$341K ﹤0.01%
21,745
+6,993
+47% +$122K
TVRD
473
Tvardi Therapeutics
TVRD
$19M
$335K ﹤0.01%
+753
New +$378K
JBHT icon
474
JB Hunt Transport Services
JBHT
$25.1B
$331K ﹤0.01%
+1,626
New +$313K
CVX icon
475
Chevron
CVX
$385B
$323K ﹤0.01%
2,750
-9,288
-77% -$1.06M

Similar funds

Jupiter Asset Management's Q4 2021 Portfolio in Review

As of Q4 2021, Jupiter Asset Management held 673 positions worth $9.11B, up 3.2% from $8.83B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Jupiter Asset Management withdrew a net $399M in Q4 2021, closing 128 positions and reducing 154 holdings. Its most notable exit was Activision Blizzard, an estimated $57.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Jupiter Asset Management opened a new position in Intel worth $109M.

  • Jupiter Asset Management's largest Q4 2021 buy was Intel: 2,103,793 shares worth $109M.
  • Jupiter Asset Management added most to Merck in Q4 2021, an estimated $72.5M increase.
  • Jupiter Asset Management's biggest Q4 2021 reduction was Microsoft, cutting an estimated $99.7M.
  • Jupiter Asset Management fully exited Activision Blizzard in Q4 2021, selling an estimated $57.6M.
  • Jupiter Asset Management's ten largest holdings make up 20% of its $9.11B portfolio in Q4 2021.
  • Jupiter Asset Management opened 125 new positions and closed 128 in Q4 2021.
  • Jupiter Asset Management's portfolio value rose 3.2% quarter-over-quarter to $9.11B.

Based on Jupiter Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.